Note 10 - Stockholders' Deficit | NOTE 10 STOCKHOLDERS' DEFICIT As of March 31, 2016, we had 10,000,000 shares of $0.001 par value preferred stock authorized and 2,000,000,000 shares of $0.0025 par value common stock authorized, retroactively restated for the increase in authorized shares. On March 3, 2016, the holders with the power to vote more than a majority of the outstanding common stock of the Company approved an amendment to the Company's Articles of Incorporation to affect an authorized share increase in our common stock from 500,000,000 shares to 2,000,000,000 shares of common stock. The amendment became effective on April 8, 2016. We have authorized the issuance of up to 1,000,000 shares of Series AA Preferred Stock. Among other things, the Series AA Preferred Stock allows holders thereof enhanced voting rights based on ten thousand (10,000) votes per share of the Company's common stock held by such holders of Series AA Preferred Stock. The Series AA Preferred Stock is not convertible into common stock, does not pay dividends, and does not include a liquidation preference. In June 2014, 20,000 shares of Series AA Preferred Stock were issued to each of the four members of the Company's Board of Directors. On January 29, 2016, Robert Hines resigned from the Board of Directors, effective December 31, 2015, at which time he returned the 20,000 shares of Series AA Preferred Stock, which were then canceled. We have also authorized the issuance of up to 1,000,000 shares of Series BB Preferred Stock. Among other things, the Series BB Preferred Stock allows holders thereof voting rights equal to holders of common stock as a single class with respect to all matters submitted to holders of common stock, quarterly dividends payable in arrears in either cash or in kind, liquidation preferences, and is convertible at the option of the holder into 50 shares of common stock of the Company. As of March 31, 2016, 186,000 shares of Series BB Preferred Stock were issued and outstanding. During the three months ended March 31, 2016, we issued a total of 25,285,602 shares of our common stock with a total value of $101,785 for conversion of debt. During the three months ended March 31, 2015, we issued a total of 80,486,541 shares of our common stock with a total value of $296,036 for conversion of debt. As of March 31, 2016, we had several convertible debentures and related accrued interest payable that were convertible into approximately 3,799,337,000 shares of our common stock. We have 2,000,000,000 common shares authorized and we will be required to again increase the number of authorized shares of common stock in the event all convertible debt is converted into shares of our common stock. As of March 31, 2016, we had certain penalties on delinquent convertible debentures and pending debenture conversions that are payable in shares of our common stock. We record these obligations at the current market value of our common stock, marking the obligations to market at each reporting date. We recognize the change in the market value as gain or loss on debt payable in shares in other income (expense) in our consolidated statements of operations. For the three months ended March 31, 2016, we recognized a gain on debt payable in shares of $354,849. |